In situ BCG-refractory Bladder carcinoma
Drug | Drug Name | Drug Description |
---|---|---|
DB00385 | Valrubicin | An anthracycline used intravesically in the treatment of BCG-resistant bladder carcinoma. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB00385 | Valrubicin | DNA topoisomerase 2-alpha | target |
DB00385 | Valrubicin | DNA | target |
Drug | Drug Name | Phase | Status | Count |
---|